TUBERCULOSIS, PULMONARY
Clinical trials for TUBERCULOSIS, PULMONARY explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOSIS, PULMONARY trials appear
Sign up with your email to follow new studies for TUBERCULOSIS, PULMONARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a 17-Week TB regimen replace 6 months of treatment?
Disease control OngoingThis study tests whether two shorter, 17-week drug combinations can treat pulmonary tuberculosis as effectively as the standard 6-month regimen. About 288 adults and teens with active TB will take one of three daily pill regimens. The goal is to see if the shorter treatments clea…
Matched conditions: TUBERCULOSIS, PULMONARY
Phase: PHASE2, PHASE3 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated May 17, 2026 06:53 UTC
-
Could a 12-Week TB drug combo replace 6-Month standard care?
Disease control OngoingThis study tests whether a 12-week combination of four drugs (bedaquiline, clofazimine, pyrazinamide, and delamanid) works better than the standard 6-month treatment for drug-susceptible tuberculosis. About 94 adults with active TB in the lungs will be randomly assigned to either…
Matched conditions: TUBERCULOSIS, PULMONARY
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 14, 2026 12:03 UTC